SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-3 - Registration statement under Securities Act of 1933:
SEC Accession No. 0001047469-18-006015
Filing Date
2018-09-07
Accepted
2018-09-06 21:43:56
Documents
6

Document Format Files

Seq Description Document Type Size
1 S-3 a2236589zs-3.htm S-3 199568
2 EX-5.1 a2236589zex-5_1.htm EX-5.1 9673
3 EX-10.1 a2236589zex-10_1.htm EX-10.1 176160
4 EX-23.1 a2236589zex-23_1.htm EX-23.1 2813
5 G921274.JPG g921274.jpg GRAPHIC 31931
6 G230562KII001.JPG g230562kii001.jpg GRAPHIC 2924
  Complete submission text file 0001047469-18-006015.txt   437687
Mailing Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160
Business Address 7707 GATEWAY BLVD., SUITE 140 NEWARK CA 94560-1160 (510) 474-0170
Protagonist Therapeutics, Inc (Filer) CIK: 0001377121 (see all company filings)

IRS No.: 980505495 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3 | Act: 33 | File No.: 333-227216 | Film No.: 181058809
SIC: 2834 Pharmaceutical Preparations